JY
OLMA icon

Jeff Yass’s Olema Pharmaceuticals OLMA Stock Holding History

Jeff Yass’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
103,700
-445,600
-81% -$5.97M ﹤0.01% 7520
2026
Q1 		$8.19M Buy
549,300
+60,400
+12% +$1.34M ﹤0.01% 3420
2025
Q4 		$12.2M Buy
+488,900
New +$8.7M ﹤0.01% 2796
2025
Q1 		– Sell
-81,000
Closed -$472K – 13175
2024
Q4 		$472K Buy
81,000
+19,800
+32% +$198K ﹤0.01% 8813
2024
Q3 		$731K Buy
61,200
+35,900
+142% +$459K ﹤0.01% 7550
2024
Q2 		$274K Buy
25,300
+3,200
+14% +$34.7K ﹤0.01% 9655
2024
Q1 		$250K Buy
22,100
+4,300
+24% +$55.5K ﹤0.01% 10118
2023
Q4 		$250K Sell
17,800
-64,400
-78% -$865K ﹤0.01% 10217
2023
Q3 		$1.02M Buy
82,200
+55,500
+208% +$566K ﹤0.01% 6598
2023
Q2 		$241K Buy
26,700
+13,200
+98% +$79.7K ﹤0.01% 9886
2023
Q1 		$46.8K Sell
13,500
-7,700
-36% -$31.4K ﹤0.01% 11720
2022
Q4 		$51.9K Sell
21,200
-22,400
-51% -$65.3K ﹤0.01% 11373
2022
Q3 		$120K Sell
43,600
-26,300
-38% -$112K ﹤0.01% 11521
2022
Q2 		$284K Buy
69,900
+45,500
+186% +$144K ﹤0.01% 9717
2022
Q1 		$104K Sell
24,400
-62,000
-72% -$342K ﹤0.01% 11878
2021
Q4 		$809K Buy
86,400
+76,600
+782% +$1.59M ﹤0.01% 7851
2021
Q3 		$270K Buy
+9,800
New +$265K ﹤0.01% 10823

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jeff Yass's OLMA Position: Q2 2026 in Review

Jeff Yass reduced its Olema Pharmaceuticals (OLMA) stake by 56% in Q2 2026, selling an estimated $2.16M and leaving 124,952 shares worth $1.56M. The position accounts for ﹤0.01% of the portfolio, ranked #7060.

Jeff Yass first reported a position in OLMA in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.26M in Q1 2026. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Jeff Yass held 124,952 shares of Olema Pharmaceuticals worth $1.56M as of Q2 2026.
  • Jeff Yass sold 160,930 Olema Pharmaceuticals shares in Q2 2026, an estimated $2.16M.
  • Olema Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #7060 holding.
  • Jeff Yass first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Jeff Yass's Olema Pharmaceuticals position peaked at $4.26M in Q1 2026.
  • 183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.